Neogen sold more, kept more of each sale, and nearly erased its operating loss in the three months ended August 31. The bottom line still went the other way.
Revenue rose 6.5% to $222.8 million from the comparable period a year earlier, while gross margin reached 47.4%. Operating income improved from a $16.1 million loss to a $1.8 million loss. That sharply narrowed the operating loss, even if the business has not quite crossed into operating profit.
Management attributes the margin improvement to the ordinary drivers of the margin improvement: more volume, higher prices, and currency. The company also pointed to lower manufacturing inefficiencies in sample collection.
"The increase in margin was primarily due to volume increases, price increases, and favorable foreign currency exchange impacts."
Neogen, 10-Q filed October 7, 2026
The important word there is “and.” Neogen did not credit the improvement to one clean lever. Sales volume, pricing, and foreign exchange all helped, with Food Safety revenue rising 7.3% and Animal Safety revenue up 4.4%.
Then the income statement changes character. Net income fell from $36.3 million to an $11.9 million loss, and diluted earnings per share moved from 17 cents to negative 5 cents. Neogen does not give one operating explanation for that reversal in the current receipts, leaving a business that looks close to breakeven above the operating line but still loss-making below it.
Cash offers a second reading. Operating cash flow rose to $12.9 million from $10.8 million, while capital spending fell 65.8%. Inventory also declined 24.5%, and accounts receivable edged down 1.6%. Those figures point to better cash conversion in the latest three months, though the company said working-capital changes related mainly to receivables and payables were a drag within the cash result.
"The increase is primarily due to an improvement in operating income offset by unfavorable changes in working capital primarily associated with accounts receivable and accounts payable."
Neogen, 10-Q filed October 7, 2026
That sentence supplies the filing's other tension: operating improvement helped cash, but working capital took some of it back. The lower capital bill helped offset the pressure. The company also reported lower outbound shipping and compensation costs tied to headcount reductions, partially offset by higher restructuring costs.
The market's latest snapshot points in a different direction from the operating lines. Neogen closed at $11.97 on October 6, down 8.2% for the day. That move does not explain the accounting split, but it puts the filing's central question in plain view: how much of the improvement is durable operating progress, and how much depends on pricing, foreign exchange, lower costs, or reduced investment?
Neogen's next quarterly report can add one useful piece of evidence by showing whether the operating line moves into profit while cash conversion holds up without another sharp reduction in capital spending. Until then, the filing leaves the same business carrying two descriptions at once.
Neogen improved its operating results, but the latest three months still ended with a net loss.